Noida, UP -- (SBWire) -- 07/16/2015 --According to a new research report by RNCOS entitled, "Global Needle Free Drug Delivery Market Outlook 2020", US industry has been witnessing higher growth in the needle free drug delivery market in the world and in the year 2014, it accounted for over 40% of the global needle free drug delivery market. The major factors that drive the industry are introduction of innovative vaccine delivery systems, rising disposable income, increasing ageing population and increasing awareness.
Needle free drug delivery systems help to increase the vaccination coverage rate in countries as they are painless and convenient, which ultimately encourages people to get vaccinated easily. Oral drug delivery system is considered to be the most demanded needle free drug delivery system in the world. The market is anticipated to grow at 9.4% CAGR to become US$ 192 Billion by 2020. GSK, Novartis, 3M, Endo International, Boehringer Ingelheim Group and AstraZeneca are major needle free drug delivery companies.
The report is spread in over 75 pages and provides an in-depth research and rational analysis of the current status and future prospect of the Global Needle Free Drug Delivery Industry. The study presents transparent picture major needle free drug delivery systems such as Jet Injector, Micro Needle, Transdermal, Oral and Inhaled systems including the factors affecting their growth. The research further covers global needle free drug delivery system industry, detailed analysis of geographical segments, applications of needle free drug delivery systems, pipeline analysis, as well as Mergers and Acquisitions.
The report also covers detailed information about active market players in the Global Needle Free Drug Delivery Industry, including small and large players to enable the clients understand the market structure and its growth during the forecasted period. In brief, the report covers all the necessary aspects of the global needle free drug delivery system industry, providing an in-depth research and prudent analysis of the key segments.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM751.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
About RNCOS
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.
Needle Free Drug Delivery Systems Set to Increase Vaccine Coverage Ratio
“Introduction of new products, increasing healthcare expenditure and increasing health consciousness will drive the global needle free drug delivery market to generate US$ 192 Billion by 2020”, says RNCOS.